Oruka Therapeutics Financial Overview
Oruka Therapeutics's market cap is currently $1.37B. The company's EPS TTM is $-0.55; its P/E ratio is -11.65; Oruka Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.
